Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05722886
What this trial is testing

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

Who this might be right for
Haematological MalignancySolid Tumour
Cancer Research UK 825
Not applicableUnknownNCT06607120
What this trial is testing

Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 950
Testing effectiveness (Phase 2)Study completedNCT01771458
What this trial is testing

Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

Who this might be right for
Reccurent/Metastatic Solid Tumor Disease
Institut Curie 742
Very early researchEnded earlyNCT04592991
What this trial is testing

CCR2 AAA Pilot Study

Who this might be right for
Abdominal Aortic Aneurysm (AAA)
Washington University School of Medicine 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07715565
What this trial is testing

Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)ImmunotherapyMolecular Targeted Therapy
West China Hospital 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06523049
What this trial is testing

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Who this might be right for
Renal Cell CarcinomaImmunotherapyMolecular Targeted Therapy
Hao Zeng 67
Not applicableStudy completedNCT01118078
What this trial is testing

Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more
Children's Oncology Group 185
Not applicableUnknownNCT05609695
What this trial is testing

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
Sun Yat-sen University 100
Not applicableNot Yet RecruitingNCT06028178
What this trial is testing

Droplet Digital PCR Combines With Transcriptome Analysis in Early Warning of Sepsis in the Emergency Department

Who this might be right for
SepsisEmergent Infections, Treatment
Shanghai East Hospital 360
Testing effectiveness (Phase 2)Study completedNCT02094872
What this trial is testing

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Yale University 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT02152254
What this trial is testing

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)

Who this might be right for
Metastatic Malignant NeoplasmRecurrent Malignant Neoplasm
M.D. Anderson Cancer Center 1,362
Not applicableStudy completedNCT04642547
What this trial is testing

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMolecular Targeted Therapy
RenJi Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04355858
What this trial is testing

Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
Fudan University 319
Not applicableActive Not RecruitingNCT05853887
What this trial is testing

Liquid Biopsy Based NGS in Newly Diagnosed NSCLC

Who this might be right for
Non Small Cell Lung Cancer MetastaticNewly Diagnosed NSCLCNon-Squamous Non-Small Cell Neoplasm of Lung
Charu Aggarwal 260
Testing effectiveness (Phase 2)Study completedNCT01827384
What this trial is testing

MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations

Who this might be right for
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI) 208
Not applicableLooking for participantsNCT04274283
What this trial is testing

Tessa Jowell BRAIN MATRIX - Platform Study

Who this might be right for
Glioma
University of Birmingham 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT02029001
What this trial is testing

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Who this might be right for
Malignant Solid Neoplasms
Centre Leon Berard 900
Not applicableUnknownNCT03521245
What this trial is testing

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
OmicsWay Corp. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802418
What this trial is testing

Molecularly Tailored Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Herlev Hospital 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Next Page